Intangible Assets and Software Development Costs

12 Months Ended

Mar. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Software Development Costs

5. Intangible Assets and Software Development Costs

The following table summarizes our intangible assets and software development costs at March 31, 2022, and 2021:

	March 31, 2022										March 31, 2021
	Gross								Net		Gross								Net
	carrying		Accumulated			Accumulated			carrying		carrying		Accumulated			Accumulated			carrying
(In thousands)	amount		amortization			Impairment			amount		amount		amortization			impairment			amount
Finite-lived intangible assets:
Customer relationships	$	20,391	$	(10,938	)	$	—		$	9,453	$	10,775	$	(10,775	)	$	—		$	—
Non-competition agreements		3,547		(2,808	)		—			739		2,700		(2,700	)		—			—
Developed technology		11,224		(10,440	)		—			784		10,398		(10,398	)		—			—
Trade names		1,075		(273	)		—			802		230		(230	)		—			—
Patented technology		80		(80	)		—			—		80		(80	)		—			—
		36,317		(24,539	)		—			11,778		24,183		(24,183	)		—			—
Indefinite-lived trade names		8,400	N/A				—			8,400		8,400	N/A				—			8,400
Total intangible assets	$	44,717	$	(24,539	)	$	—		$	20,178	$	32,583	$	(24,183	)	$	—		$	8,400
(In thousands)
Software development costs	$	67,541	$	(45,535	)	$	(22,006	)	$	—	$	67,541	$	(45,535	)	$	(22,006	)	$	—

Total amortization expense for finite-lived intangible assets was $0.4 million for the year ended March 31, 2022 and zero for the years ended March 31, 2021, and 2020, respectively. See Note 15, Business Combination, for more information on the acquisition of finite-lived intangible assets.

Estimated future amortization expense on finite-lived intangible assets is as follows:

(In thousands)	Estimated Amortization Expense
Fiscal year ending March 31,
2023	$	1,398
2024		1,293
2025		975
2026		975
2027		892
Thereafter		6,245
Total	$	11,778

Indefinite-lived intangible assets, comprised of our purchased trade name InfoGenesis as of March 31, 2022 and 2021 are tested for impairment upon identification of impairment indicators or at least annually. An impairment loss is recognized if the carrying amount is greater than fair value. The InfoGenesis indefinite-lived purchased trade name impairment testing resulted in a fair value exceeding the carrying amount for the years ending March 31, 2022, 2021 and 2020.

Amortization expense related to software development costs related to assets to be sold, leased, or otherwise marketed was $12.6 million for the fiscal year ended March 31, 2020. These charges are included as Products cost of goods sold within the Consolidated Statements of Operations.